Updated HER2 In Situ Hybridization (ISH) Guidelines in Breast Cancer: Some Equivocal Findings

被引：0
|
作者：
Kos, Zuzana [1 ]
Craddock, Kenneth [1 ]
Berman, Hal [1 ]
Done, Susan [1 ]
Miller, Naomi [1 ]
Youngson, Bruce [1 ]
Mulligan, Anna Marie [1 ]
机构：
[1] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
194
引用
收藏
页码：51A / 52A
页数：2
相关论文
共 50 条
  • [1] Updated HER2 In Situ Hybridization (ISH) Guidelines in Breast Cancer: Some Equivocal Findings
    Kos, Zuzana
    Craddock, Kenneth
    Berman, Hal
    Done, Susan
    Miller, Naomi
    Youngson, Bruce
    Mulligan, Anna Marie
    MODERN PATHOLOGY, 2015, 28 : 51A - 52A
  • [2] Impact of Updated HER2 Guidelines on Immunohistochemical HER2-Equivocal Breast Carcinomas
    Lewin, Eleanor
    Mehr, Chelsea
    Collins, Laura
    Quintana, Liza
    MODERN PATHOLOGY, 2019, 32
  • [3] Impact of Updated HER2 Guidelines on Immunohistochemical HER2-Equivocal Breast Carcinomas
    Lewin, Eleanor
    Mehr, Chelsea
    Collins, Laura
    Quintana, Liza
    LABORATORY INVESTIGATION, 2019, 99
  • [4] Dual-Color In Situ Hybridization (Dual ISH) for Evaluation of HER2/Neu (HER2) Amplification in Breast Cancer
    Astvatsaturyan, K.
    Bose, S.
    MODERN PATHOLOGY, 2013, 26 : 28A - 28A
  • [5] Dual-Color In Situ Hybridization (Dual ISH) for Evaluation of HER2/Neu (HER2) Amplification in Breast Cancer
    Astvatsaturyan, K.
    Bose, S.
    LABORATORY INVESTIGATION, 2013, 93 : 28A - 28A
  • [6] Reproducibility of equivocal HER2 in situ hybridisation (ISH) results in invasive breast cancer, and correlation with HER2 mRNA expression as determined by Mammatyper®
    Riggi, J. A. M.
    Baez-Navarro, X.
    Zylberberg, D.
    van der Made, A.
    Dubois, D.
    Vanderveken, J.
    Benhaddi, N.
    Duhoux, F. P.
    Vernaeve, H.
    Vassilieff, M.
    Berliere, M.
    Galant, C.
    van Deurzen, C. H. M.
    van Bockstal, M. R.
    BREAST, 2025, 80
  • [7] HER2 testing in metastatic breast cancer - is reflex in situ hybridization necessary in cases that are equivocal by immunohistochemistry?
    Liwski, C. R.
    Castonguay, M.
    Barnes, P.
    Bethune, G.
    Rayson, D.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 156 : S27 - S28
  • [8] 2018 ASCO/CAP Her2 Testing Guidelines in Breast Cancer. Impact of the Updated Guidelines on Breast Carcinomas Originally Classified as Her2 Equivocal - A Retrospective Analysis
    Alzeer, Ali
    Zeck, Jay
    Laureano, Julio
    Sidawy, Mary
    LABORATORY INVESTIGATION, 2019, 99
  • [9] 2018 ASCO/CAP Her2 Testing Guidelines in Breast Cancer. Impact of the Updated Guidelines on Breast Carcinomas Originally Classified as Her2 Equivocal - A Retrospective Analysis
    Alzeer, Ali
    Zeck, Jay
    Laureano, Julio
    Sidawy, Mary
    MODERN PATHOLOGY, 2019, 32
  • [10] Resolving Equivocal HER2 Status in Breast Cancer by Automated and Quantitative RNA Chromogenic In Situ Hybridization (CISH)
    Wang, Z.
    Bui, S.
    Wang, H.
    Su, N.
    Ma, X-J
    Luo, Y.
    Tubbs, R. R.
    MODERN PATHOLOGY, 2012, 25 : 72A - 72A
12345